Latest Transformation News

SkyCity Entertainment Group reports a 5% revenue decline in FY25 amid economic headwinds and elevated investments, announcing a $240 million equity raise to bolster its balance sheet ahead of the NZICC opening and online gaming launch.

Universal Store Holdings reported a robust FY25 with 15.5% revenue growth to $333.3 million, driven by strong like-for-like sales and new store openings. Despite a goodwill impairment in its CTC segment, the group declared a solid final dividend and advanced its sustainability agenda.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Downer EDI Limited reported a robust FY25 with a 33% rise in underlying NPATA and announced a $230 million share buy-back, underscoring confidence in its transformation and growth outlook. The company’s disciplined portfolio simplification and operational improvements set the stage for steady FY26 performance despite short-term market softness.

Downer EDI reports a robust FY25 with statutory profit soaring 82% and announces a $230 million share buy-back, signaling confidence in its ongoing transformation.

Vault Minerals announces that CEO Luke Tonkin will step down within the next 12 months, triggering a leadership transition as the company continues to build on recent operational successes.

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.

Whitehaven Coal reported a 53% revenue increase to $5.83 billion in FY25, driven by full-year contributions from its Queensland acquisitions. Despite a cyclical price downturn, the company strengthened its balance sheet and declared a fully franked final dividend of 6 cents per share.

Equity Trustees reports record funds under management of $254 billion and a 60% jump in statutory net profit, completing a transformative three-year strategic agenda.

EQT Holdings Limited reported a robust FY25 with a 60% jump in net profit and record funds under management, while completing a major acquisition integration and raising dividends.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion driven by volume growth and strategic acquisitions, while profits declined amid inflationary pressures. The company declared a final dividend of 6.5 cents per share and maintains zero net debt.

Telix Pharmaceuticals reported a robust 63% revenue increase in H1 2025, driven by commercial growth and strategic investments, while advancing key clinical trials and maintaining full-year guidance.